메뉴 건너뛰기




Volumn 29, Issue 158, 2020, Pages 1-13

Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: A systematic review and meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; PLACEBO; BRONCHO-VAXOM; CELL EXTRACT;

EID: 85088560731     PISSN: 09059180     EISSN: 16000617     Source Type: Journal    
DOI: 10.1183/16000617.0175-2019     Document Type: Review
Times cited : (49)

References (53)
  • 1
    • 84940643725 scopus 로고    scopus 로고
    • National and regional asthma programmes in Europe
    • Selroos O, Kupczyk M, Kuna P, et al. National and regional asthma programmes in Europe. Eur Respir Rev 2015; 24: 474–483.
    • (2015) Eur Respir Rev , vol.24 , pp. 474-483
    • Selroos, O1    Kupczyk, M2    Kuna, P3
  • 3
    • 85018884308 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease
    • Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet 2017; 389: 1931–1940.
    • (2017) Lancet , vol.389 , pp. 1931-1940
    • Rabe, KF1    Watz, H.2
  • 4
    • 85031844868 scopus 로고    scopus 로고
    • Role of viral infections in the development and exacerbation of asthma in children
    • Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J Allergy Clin Immunol 2017; 140: 895–906.
    • (2017) J Allergy Clin Immunol , vol.140 , pp. 895-906
    • Jartti, T1    Gern, JE.2
  • 5
    • 84864465825 scopus 로고    scopus 로고
    • Diagnosis and management of early asthma in preschool-aged children
    • Bacharier LB, Guilbert TW. Diagnosis and management of early asthma in preschool-aged children. J Allergy Clin Immunol 2012; 130: 287–296.
    • (2012) J Allergy Clin Immunol , vol.130 , pp. 287-296
    • Bacharier, LB1    Guilbert, TW.2
  • 6
    • 84897401109 scopus 로고    scopus 로고
    • Classification and pharmacological treatment of preschool wheezing: changes since 2008
    • Brand PL, Caudri D, Eber E, et al. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J 2014; 43: 1172–1177.
    • (2014) Eur Respir J , vol.43 , pp. 1172-1177
    • Brand, PL1    Caudri, D2    Eber, E3
  • 7
    • 85075469267 scopus 로고    scopus 로고
    • Preschool wheezing diagnosis and management: survey of physicians’ and caregivers’ perspective
    • Adamiec A, Ambrozej D, Ryczaj K, et al. Preschool wheezing diagnosis and management: survey of physicians’ and caregivers’ perspective. Pediatr Allergy Immunol 2020; 31: 206–209.
    • (2020) Pediatr Allergy Immunol , vol.31 , pp. 206-209
    • Adamiec, A1    Ambrozej, D2    Ryczaj, K3
  • 8
    • 85038583973 scopus 로고    scopus 로고
    • The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations
    • Edwards MR, Walton RP, Jackson DJ, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations. Allergy 2018; 73: 50–63.
    • (2018) Allergy , vol.73 , pp. 50-63
    • Edwards, MR1    Walton, RP2    Jackson, DJ3
  • 9
    • 84926253393 scopus 로고    scopus 로고
    • The prevalence of severe refractory asthma
    • Hekking PP, Wener RR, Amelink M, et al. The prevalence of severe refractory asthma. J Allergy Clin Immunol 2015; 135: 896–902.
    • (2015) J Allergy Clin Immunol , vol.135 , pp. 896-902
    • Hekking, PP1    Wener, RR2    Amelink, M3
  • 10
    • 84899066468 scopus 로고    scopus 로고
    • Asthma: NHLBI workshop on the primary prevention of chronic lung diseases
    • Suppl. 3
    • Jackson DJ, Hartert TV, Martinez FD, et al. Asthma: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014; 11: Suppl. 3, S139–S145.
    • (2014) Ann Am Thorac Soc , vol.11 , pp. S139-S145
    • Jackson, DJ1    Hartert, TV2    Martinez, FD3
  • 11
    • 77956742179 scopus 로고    scopus 로고
    • Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study
    • van der Meer V, van Stel HF, Bakker MJ, et al. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: an analysis of the SMASHING study. Respir Res 2010; 11: 74.
    • (2010) Respir Res , vol.11 , pp. 74
    • van der Meer, V1    van Stel, HF2    Bakker, MJ3
  • 12
    • 85053730636 scopus 로고    scopus 로고
    • Viral infections in wheezing disorders
    • Le Souef P. Viral infections in wheezing disorders. Eur Respir Rev 2018; 27: 170133.
    • (2018) Eur Respir Rev , vol.27 , pp. 170133
    • Le Souef, P.1
  • 13
    • 85046705072 scopus 로고    scopus 로고
    • Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence
    • Esposito S, Soto-Martinez ME, Feleszko W, et al. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. Curr Opin Allergy Clin Immunol 2018; 18: 198–209.
    • (2018) Curr Opin Allergy Clin Immunol , vol.18 , pp. 198-209
    • Esposito, S1    Soto-Martinez, ME2    Feleszko, W3
  • 14
    • 85029412074 scopus 로고    scopus 로고
    • Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways
    • Cirauqui C, Benito-Villalvilla C, Sanchez-Ramon S, et al. Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways. Eur J Immunol 2018; 48: 180–193.
    • (2018) Eur J Immunol , vol.48 , pp. 180-193
    • Cirauqui, C1    Benito-Villalvilla, C2    Sanchez-Ramon, S3
  • 15
    • 38749118225 scopus 로고    scopus 로고
    • Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view
    • Cazzola M, Rogliani P, Curradi G. Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view. Respir Med 2008; 102: 321–327.
    • (2008) Respir Med , vol.102 , pp. 321-327
    • Cazzola, M1    Rogliani, P2    Curradi, G.3
  • 17
    • 0026975883 scopus 로고
    • Broncho-vaxom in the treatment and prophylaxis of recurrent respiratory tract infections in bronchial asthma
    • Suppl. 2
    • Chyrek-Borowska S, Moniuszko T, Szymanski W, et al. Broncho-vaxom in the treatment and prophylaxis of recurrent respiratory tract infections in bronchial asthma. Pneumonol Alergol Pol 1992; 60: Suppl. 2, 117–119.
    • (1992) Pneumonol Alergol Pol , vol.60 , pp. 117-119
    • Chyrek-Borowska, S1    Moniuszko, T2    Szymanski, W3
  • 18
    • 84929512015 scopus 로고    scopus 로고
    • Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma
    • Kearney SC, Dziekiewicz M, Feleszko W. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma. Ann Allergy Asthma Immunol 2015; 114: 364–369.
    • (2015) Ann Allergy Asthma Immunol , vol.114 , pp. 364-369
    • Kearney, SC1    Dziekiewicz, M2    Feleszko, W.3
  • 19
    • 84992462683 scopus 로고    scopus 로고
    • Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract
    • Pasquali C, Salami O, Taneja M, et al. Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract. Front Med (Lausanne) 2014; 1: 41.
    • (2014) Front Med (Lausanne) , vol.1 , pp. 41
    • Pasquali, C1    Salami, O2    Taneja, M3
  • 20
    • 85034087196 scopus 로고    scopus 로고
    • Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis
    • Yin J, Xu B, Zeng X, et al. Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis. Int Immunopharmacol 2018; 54: 198–209.
    • (2018) Int Immunopharmacol , vol.54 , pp. 198-209
    • Yin, J1    Xu, B2    Zeng, X3
  • 21
    • 84893609201 scopus 로고    scopus 로고
    • Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway
    • Parola C, Salogni L, Vaira X, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway. PLoS One 2013; 8: e82867.
    • (2013) PLoS One , vol.8 , pp. e82867
    • Parola, C1    Salogni, L2    Vaira, X3
  • 22
    • 78650807878 scopus 로고    scopus 로고
    • The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways
    • Navarro S, Cossalter G, Chiavaroli C, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of regulatory T cells to the airways. Mucosal Immunol 2011; 4: 53–65.
    • (2011) Mucosal Immunol , vol.4 , pp. 53-65
    • Navarro, S1    Cossalter, G2    Chiavaroli, C3
  • 23
    • 78650813165 scopus 로고    scopus 로고
    • Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control
    • Strickland DH, Judd S, Thomas JA, et al. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol 2011; 4: 43–52.
    • (2011) Mucosal Immunol , vol.4 , pp. 43-52
    • Strickland, DH1    Judd, S2    Thomas, JA3
  • 24
    • 84872011968 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
    • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1–34.
    • (2009) J Clin Epidemiol , vol.62 , pp. e1-34
    • Liberati, A1    Altman, DG2    Tetzlaff, J3
  • 25
    • 84925548115 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009; 62: 1006–1012.
    • (2009) J Clin Epidemiol , vol.62 , pp. 1006-1012
    • Moher, D1    Liberati, A2    Tetzlaff, J3
  • 26
    • 84964921069 scopus 로고    scopus 로고
    • Review Manager (RevMan)
    • Version 5.3. Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration
    • Review Manager (RevMan). Version 5.3. Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration. 2014.
    • (2014)
  • 28
    • 84976585919 scopus 로고    scopus 로고
    • OM-Pharma
    • OM-Pharma. 2016. Summary of Product Characteristics. https://myhealthbox.eu/nl/view/1717481/1229962e24dc 324b4c23f24db468f6ec/leaflet.
    • (2016) Summary of Product Characteristics
  • 29
    • 85047844810 scopus 로고    scopus 로고
    • Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children: The EOLIA study
    • Emeryk A, Bartkowiak-Emeryk M, Raus Z, et al. Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children: The EOLIA study. Pediatr Allergy Immunol 2018; 29: 394–401.
    • (2018) Pediatr Allergy Immunol , vol.29 , pp. 394-401
    • Emeryk, A1    Bartkowiak-Emeryk, M2    Raus, Z3
  • 30
    • 84979052786 scopus 로고    scopus 로고
    • Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections
    • Koatz AM, Coe NA, Ciceran A, et al. Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections. Lung 2016; 194: 687–697.
    • (2016) Lung , vol.194 , pp. 687-697
    • Koatz, AM1    Coe, NA2    Ciceran, A3
  • 31
    • 76749131484 scopus 로고    scopus 로고
    • Immunoregulants improves the prognosis of infants with wheezing
    • Chen ZG, Ji JZ, Li M, et al. [Immunoregulants improves the prognosis of infants with wheezing]. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1612–1613.
    • (2007) Nan Fang Yi Ke Da Xue Xue Bao , vol.27 , pp. 1612-1613
    • Chen, ZG1    Ji, JZ2    Li, M3
  • 32
    • 84984813515 scopus 로고    scopus 로고
    • Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom
    • Han RF, Li HY, Wang JW, et al. Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom. Eur Rev Med Pharmacol Sci 2016; 20: 2151–2155.
    • (2016) Eur Rev Med Pharmacol Sci , vol.20 , pp. 2151-2155
    • Han, RF1    Li, HY2    Wang, JW3
  • 33
    • 85067662799 scopus 로고    scopus 로고
    • Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85
    • Sly PD, Galbraith S, Islam Z, et al. Primary prevention of severe lower respiratory illnesses in at-risk infants using the immunomodulator OM-85. J Allergy Clin Immunol 2019; 144: 870–872.
    • (2019) J Allergy Clin Immunol , vol.144 , pp. 870-872
    • Sly, PD1    Galbraith, S2    Islam, Z3
  • 34
    • 84902574120 scopus 로고    scopus 로고
    • Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection
    • Liao JY, Zhang T. [Influence of OM-85 BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection]. Zhongguo Dang Dai Er Ke Za Zhi 2014; 16: 508–512.
    • (2014) Zhongguo Dang Dai Er Ke Za Zhi , vol.16 , pp. 508-512
    • Liao, JY1    Zhang, T.2
  • 35
    • 84926142680 scopus 로고    scopus 로고
    • Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children
    • Lu Y, Li Y, Xu L, et al. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children. Pharmacology 2015; 95: 139–144.
    • (2015) Pharmacology , vol.95 , pp. 139-144
    • Lu, Y1    Li, Y2    Xu, L3
  • 36
    • 77957783557 scopus 로고    scopus 로고
    • The immunostimulant OM-85 BV prevents wheezing attacks in preschool children
    • Razi CH, Harmanci K, Abaci A, et al. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol 2010; 126: 763–769.
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 763-769
    • Razi, CH1    Harmanci, K2    Abaci, A3
  • 37
    • 85097948793 scopus 로고    scopus 로고
    • Bacterial immunotherapy in children with wheezing attacks: clinical impact and mechanism of action
    • Suppl. 63, PA4998
    • Conejero L, Nieto A, Brandi P, et al. Bacterial immunotherapy in children with wheezing attacks: clinical impact and mechanism of action. Eur Respir J 2019; 54: Suppl. 63, PA4998.
    • (2019) Eur Respir J , vol.54
    • Conejero, L1    Nieto, A2    Brandi, P3
  • 38
    • 85046798942 scopus 로고    scopus 로고
    • Effect and analysis of clinical efficacy of immunomodulator on serum levels of IL-4 and IFN-gamma in asthmatic children
    • Chen ZG, Ji JZ, Li M, et al. Effect and analysis of clinical efficacy of immunomodulator on serum levels of IL-4 and IFN-gamma in asthmatic children. J Sun Yat-sen Univ Med Sci 2009; 30: 3.
    • (2009) J Sun Yat-sen Univ Med Sci , vol.30 , pp. 3
    • Chen, ZG1    Ji, JZ2    Li, M3
  • 39
    • 85058888907 scopus 로고    scopus 로고
    • Effects of montelukast sodium and bacterial lysates on airway remodeling and expression of transforming growth factor-beta1 and Smad7 in guinea pigs with bronchial asthma
    • Liao JY, Zhang T. [Effects of montelukast sodium and bacterial lysates on airway remodeling and expression of transforming growth factor-beta1 and Smad7 in guinea pigs with bronchial asthma]. Zhongguo Dang Dai Er Ke Za Zhi 2018; 20: 1063–1069.
    • (2018) Zhongguo Dang Dai Er Ke Za Zhi , vol.20 , pp. 1063-1069
    • Liao, JY1    Zhang, T.2
  • 40
    • 85017492987 scopus 로고    scopus 로고
    • Bacterial extract (OM-85) with human-equivalent doses does not inhibit the development of asthma in a murine model
    • Rodrigues A, Gualdi LP, de Souza RG, et al. Bacterial extract (OM-85) with human-equivalent doses does not inhibit the development of asthma in a murine model. Allergol Immunopathol (Madr) 2016; 44: 504–511.
    • (2016) Allergol Immunopathol (Madr) , vol.44 , pp. 504-511
    • Rodrigues, A1    Gualdi, LP2    de Souza, RG3
  • 41
    • 0024477574 scopus 로고
    • Broncho-Vaxom inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187
    • Nemeth A, Magyar P. Broncho-Vaxom inhibits histamine release from rat mast cells induced by compound 48/80 and ionophore A23187. Agents Actions 1989; 27: 43–45.
    • (1989) Agents Actions , vol.27 , pp. 43-45
    • Nemeth, A1    Magyar, P.2
  • 42
    • 85018745915 scopus 로고    scopus 로고
    • The immunotherapeutic role of bacterial lysates in a mouse model of asthma
    • Liu C, Huang R, Yao R, et al. The immunotherapeutic role of bacterial lysates in a mouse model of asthma. Lung 2017; 195: 563–569.
    • (2017) Lung , vol.195 , pp. 563-569
    • Liu, C1    Huang, R2    Yao, R3
  • 43
    • 84899811239 scopus 로고    scopus 로고
    • Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3beta-related T regulatory cell insufficiency
    • Fu R, Li J, Zhong H, et al. Broncho-Vaxom attenuates allergic airway inflammation by restoring GSK3beta-related T regulatory cell insufficiency. PloS One 2014; 9: e92912.
    • (2014) PloS One , vol.9 , pp. e92912
    • Fu, R1    Li, J2    Zhong, H3
  • 44
    • 85035813115 scopus 로고    scopus 로고
    • Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP
    • Roth M, Pasquali C, Stolz D, et al. Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP. PloS One 2017; 12: e0188010.
    • (2017) PloS One , vol.12 , pp. e0188010
    • Roth, M1    Pasquali, C2    Stolz, D3
  • 45
    • 0030059684 scopus 로고    scopus 로고
    • Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element
    • Keul R, Roth M, Papakonstantinou E, et al. Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element. Thorax 1996; 51: 150–154.
    • (1996) Thorax , vol.51 , pp. 150-154
    • Keul, R1    Roth, M2    Papakonstantinou, E3
  • 46
    • 0023190858 scopus 로고
    • Effect of Broncho-Vaxom on serum IgE and IgG levels in patients with bronchial asthma and chronic obstructive lung disease. A placebo-controlled double-blind study
    • Weiss S, Fux T. [Effect of Broncho-Vaxom on serum IgE and IgG levels in patients with bronchial asthma and chronic obstructive lung disease. A placebo-controlled double-blind study]. Schweiz Med Wochenschr 1987; 117: 1514–1518.
    • (1987) Schweiz Med Wochenschr , vol.117 , pp. 1514-1518
    • Weiss, S1    Fux, T.2
  • 47
    • 84897134581 scopus 로고    scopus 로고
    • A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice
    • Han L, Zheng CP, Sun YQ, et al. A bacterial extract of OM-85 Broncho-Vaxom prevents allergic rhinitis in mice. Am J Rhinol Allergy 2014; 28: 110–116.
    • (2014) Am J Rhinol Allergy , vol.28 , pp. 110-116
    • Han, L1    Zheng, CP2    Sun, YQ3
  • 48
    • 84876900786 scopus 로고    scopus 로고
    • Bacterial lysates in food allergy prevention
    • Lau S. Bacterial lysates in food allergy prevention. Curr Opin Allergy Clin Immunol 2013; 13: 293–295.
    • (2013) Curr Opin Allergy Clin Immunol , vol.13 , pp. 293-295
    • Lau, S.1
  • 49
    • 34047197836 scopus 로고    scopus 로고
    • Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma
    • Feleszko W, Jaworska J, Rha RD, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007; 37: 498–505.
    • (2007) Clin Exp Allergy , vol.37 , pp. 498-505
    • Feleszko, W1    Jaworska, J2    Rha, RD3
  • 50
    • 84884562690 scopus 로고    scopus 로고
    • Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials
    • Elazab N, Mendy A, Gasana J, et al. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics 2013; 132: e666–e676.
    • (2013) Pediatrics , vol.132 , pp. e666-e676
    • Elazab, N1    Mendy, A2    Gasana, J3
  • 51
    • 84890081710 scopus 로고    scopus 로고
    • Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis
    • Azad MB, Coneys JG, Kozyrskyj AL, et al. Probiotic supplementation during pregnancy or infancy for the prevention of asthma and wheeze: systematic review and meta-analysis. BMJ 2013; 347: f6471.
    • (2013) BMJ , vol.347 , pp. f6471
    • Azad, MB1    Coneys, JG2    Kozyrskyj, AL3
  • 52
    • 85068992340 scopus 로고    scopus 로고
    • GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents
    • Reddel HK, FitzGerald JM, Bateman ED, et al. GINA 2019: a fundamental change in asthma management: treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents. Eur Respir J 2019; 53: 1901046.
    • (2019) Eur Respir J , vol.53 , pp. 1901046
    • Reddel, HK1    FitzGerald, JM2    Bateman, ED3
  • 53
    • 84952639251 scopus 로고    scopus 로고
    • Acute and chronic systemic corticosteroid-related complications in patients with severe asthma
    • Lefebvre P, Duh MS, Lafeuille MH, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol 2015; 136: 1488–1495.
    • (2015) J Allergy Clin Immunol , vol.136 , pp. 1488-1495
    • Lefebvre, P1    Duh, MS2    Lafeuille, MH3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.